Morning salivary dehydroepiandrosterone (DHEA) qualifies as the only neuroendocrine biomarker separating depressed patients with and without prior history of …
A Agorastos, A Heinig, A Sommer… - Journal of Psychiatric …, 2023 - Elsevier
Background Hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depression
(MDD) have been consistently reported in psychiatry and extend to several neurosteroids …
(MDD) have been consistently reported in psychiatry and extend to several neurosteroids …
Morning salivary dehydroepiandrosterone (DHEA) qualifies as the only neuroendocrine biomarker separating depressed patients with and without prior history of …
A Agorastos, A Heinig, A Sommer… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depression
(MDD) have been consistently reported in psychiatry and extend to several neurosteroids …
(MDD) have been consistently reported in psychiatry and extend to several neurosteroids …
Morning salivary dehydroepiandrosterone (DHEA) qualifies as the only neuroendocrine biomarker separating depressed patients with and without prior history of …
A Agorastos, A Heinig, A Sommer… - Journal of Psychiatric …, 2023 - europepmc.org
Background Hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depression
(MDD) have been consistently reported in psychiatry and extend to several neurosteroids …
(MDD) have been consistently reported in psychiatry and extend to several neurosteroids …